Globestar TherapeuticsGSTC
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Globestar Therapeutics Corp. (GSTC) in their 13F filings. The largest holder was Ancora Advisors LLC ($79).
- Company
- Globestar Therapeutics Corp.
- CUSIP
- 37960P104
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Ancora Advisors LLC | 0.00% | No change | 88,000 | $79 |
"% of holder's portfolio" is GSTC's weight in each manager's 13F, not the share of Globestar Therapeutics Corp. the manager owns.